1Poggi, M M, Danforth, D N, Sciuto, L Cet al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003; 98 (4): 697–702.
2Mackillop, W J. Killing time: the consequences of delays in radiotherapy. Radiother Oncol 2007; 84: 1–4.
3Tubiana, M. Repopulation in human tumors, a biological background for fractionation in radiotherapy. Acta Oncol 1988; 27: 83–88.
4Chen, Z, King, W, Pearcey, R, Kerba, M, Mackillop, W J. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol 2008; 87: 3–16.
5Huang, J, Barbera, L, Brouwers, M, Browman, G, William, J, Mackillop, W J. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003; 21: 555–563.
6Olivotto, I A, Lesperance, M L, Truong, P Tet al. Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. J Clin Oncol 2009; 27 (1): 16–23.
7Punglia, R S, Saito, A M, Neville, B A, Earle, C C, Weeks, J C. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. BMJ 2010; 340: c845.
8Yock, T I, Taghian, A G, Kachnic, L A, Coen, J J, Assaad, S I, Powell, S N. The effect of delaying radiation therapy for systemic chemotherapy on local-regional control in breast cancer. Breast Cancer Res Treat 2004; 84: 161–171.
9Benchalal, M, Boisselier, P, de Lafontan, Bet al. Influence of the delay between conservative surgery and radiation therapy on local relapse in node-positive breast tumor. Bull Cancer 2006; 93 (3): 303–313.
10Hickey, B E, Francis, D P, Lehman, M. Sequencing of chemotherapy and radiotherapy for early breast cancer (review). Cochrane Database Syst Rev 2013; 30 (4): CD005212, doi: 10.1002/14651858.CD005212.pub3.
11Corradini, S, Niemoeller, O M, Niyazi, Met al. Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution. Strahlenther Onkol 2014; 190: 352–357.
12Hébert-Croteau, N, Freeman, C R, Latreille, J, Brisson, J. Delay in adjuvant radiation treatment and outcomes of breast cancer review. Breast Cancer Res Treat 2003; 74: 77–94.
13Recht, A. Impact on outcome of delay in starting radiotherapy. J Clin Oncol 2004; 22: 1341–1342.
14Jack, R H, Davies, E A, Robinson, D, Sainsbury, R, Moller, H. Radiotherapy waiting times for women with breast cancer: a population-based cohort study. BMC Cancer 2007; 7: 71.
15Johnston, G M, MacGarvie, V L, Elliott, D, Dewar, R A, MacIntyre, M M, Nolan, M C. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000. Clin Invest Med 2004; 27: 142–156.
16Mackillop, W J, Fu, H, Quirt, C F, Dixon, P, Brundage, M, Zhou, Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994; 30: 221–228.
17Tsoutsou, P G, Koukourakis, M I, Azria, D, Belkacemi, Y. Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives. Crit Rev Oncol Hematol 2009; 71: 102–116.
18Mikeljevic, J S, Haward, R, Johnston, Cet al. Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservations surgery. Br J Cancer 2004; 90 (7): 1343–1348.
19Singletary, S E, Greene, F L, Breast Task Force. Revision of breast cancer staging: the 6th edition of the TNM Classification. Semin Surg Oncol 2003; 21 (1): 53–59.
20Clarke, M, Collins, R, Darby, Set al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087–2106.
21Nixon, A J, Neuberg, D, Hayes, D Fet al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12 (5): 888–894.
22Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365 (9472): 1687–1717.
23Mass, H, Engle, B, Trams, G. Steroid hormone receptors in human breast cancer and the clinical significance. J Steroid Biochem 1975; 6: 743–749.
24Rosen, P R, Groshen, S, Saigo, P E, Kinne, D W, Hellman, S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7 (3): 355–366.
25Ciatto, S, Biggeri, A, Rosselli Del Turco, M, Bartoli, D, Iossa, A. Risk of breastcancer subsequent to proven gross cystic disease. Eur J Cancer 1990; 26: 555–557.
26Fuentes, M J, Piedrafita, E, Isern, Jet al. Recidivas locorregionales tras el tratamiento conservador del cáncer de mama en estadios I y II. Med Clin (Barc) 2002; 118 (5): 161–165.
27Gegúndez, C, Monjero, I, Martín, M Vet al. Enfermedad residual después de cirugía conservadora por cáncer de mama. Prog Obstet Ginecol 2009; 52 (8): 437–442.
28Veronesi, U, Salvadori, B, Luini, Aet al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 1990; 211 (3): 250–259.
29Neff, P, Bear, H, Pierce, C. Long-term results of breast conservation therapy for breast cancer. Ann Surg 1996; 223 (6): 709–717.
30Agarwal, S, Pappas, L, Neumayer, L, Kokeny, K, Agarwal, J. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg 2014; 149 (3): 267–274.
31Klein, C A. Parallel progression of primary tumors and metastases. Nat Rev Cancer 2009; 9: 302–312.
32Bouche, G, Ingrand, I, Mathoulin-Pelissier, S, Ingrand, P, Breton-Callu, C, Migeot, V. Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer. Ratiother Oncol 2010; 97: 541–547.